Literature DB >> 17160554

The central role of osteoblasts in the metastasis of prostate cancer.

Michel B Choueiri1, Shi-Ming Tu, Li-Yuan Yu-Lee, Sue-Hwa Lin.   

Abstract

Prostate cancer (PCa) is the most common malignancy in men. Although mortality from PCa has been declining over the past decade, metastasis can substantially shorten survival time and remains a major challenge in maintaining quality of life for survivors. PCa cells preferentially metastasize to bone and typically result in osteoblastic lesions. In the late stages of disease, however, osteolytic lesions are observed. The mechanisms of PCa bone metastasis are still unclear, but relationships between the PCa cells and the bone tissue elements are suspected of being more complex than initially thought. Far from being an innocent bystander, the bone participates actively in the metastatic process and provides the cancer cells with growth factors and a fertile environment. Among the various cells in the bone environment, osteoblasts have a central role through their bidirectional interactions with the PCa cells. This review discusses the possible mechanisms of PCa bone metastasis and highlights the essential role of osteoblasts in the metastasis of PCa to bone.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17160554     DOI: 10.1007/s10555-006-9034-y

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  11 in total

1.  Small-molecule protein tyrosine kinase inhibitors for the treatment of metastatic prostate cancer.

Authors:  Gary E Gallick; Paul G Corn; Amado J Zurita; Sue-Hwa Lin
Journal:  Future Med Chem       Date:  2012-01       Impact factor: 3.808

2.  Protease-activated receptor-1 is upregulated in reactive stroma of primary prostate cancer and bone metastasis.

Authors:  Xiaotun Zhang; Wenbin Wang; Lawrence D True; Robert L Vessella; Thomas K Takayama
Journal:  Prostate       Date:  2009-05-15       Impact factor: 4.104

3.  Integrin αvβ6 promotes an osteolytic program in cancer cells by upregulating MMP2.

Authors:  Anindita Dutta; Jing Li; Huimin Lu; Jacqueline Akech; Jitesh Pratap; Tao Wang; Brad J Zerlanko; Thomas J FitzGerald; Zhong Jiang; Ruth Birbe; John Wixted; Shelia M Violette; Janet L Stein; Gary S Stein; Jane B Lian; Lucia R Languino
Journal:  Cancer Res       Date:  2014-01-02       Impact factor: 12.701

4.  Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in prostate cancer bone metastasis.

Authors:  Diptiman Chanda; Tatyana Isayeva; Sanjay Kumar; Jonathan A Hensel; Anandi Sawant; Girish Ramaswamy; Gene P Siegal; Matthew S Beatty; Selvarangan Ponnazhagan
Journal:  Clin Cancer Res       Date:  2009-11-17       Impact factor: 12.531

5.  A 45-kDa ErbB3 secreted by prostate cancer cells promotes bone formation.

Authors:  S-H Lin; C-J Cheng; Y-C Lee; X Ye; W-W Tsai; J Kim; R Pasqualini; W Arap; N M Navone; S-M Tu; M Hu; L-Y Yu-Lee; C J Logothetis
Journal:  Oncogene       Date:  2008-05-19       Impact factor: 9.867

6.  EB1089 inhibits the parathyroid hormone-related protein-enhanced bone metastasis and xenograft growth of human prostate cancer cells.

Authors:  Vandanajay Bhatia; Manjit K Saini; Xiaoli Shen; Lian X Bi; Suimin Qiu; Nancy L Weigel; Miriam Falzon
Journal:  Mol Cancer Ther       Date:  2009-07-07       Impact factor: 6.261

7.  Diffuse osteosclerosis in a patient with prostate cancer.

Authors:  N Ustün; I Ustün; T Ozgür; N Atci; F Aydoğan; A T Sümbül; A D Turhanoğlu
Journal:  Osteoporos Int       Date:  2013-10-18       Impact factor: 4.507

Review 8.  Systematic Review of the Outcomes of Surgical Treatment of Prostate Metastases to the Spine.

Authors:  Michelle J Clarke; Camilo A Molina; Daryl R Fourney; Charles G Fisher; Ziya L Gokaslan; Meic H Schmidt; Laurence D Rhines; Michael G Fehlings; Ilya Laufer; Shreyaskumar R Patel; Y Raja Rampersaud; Jeremy Reynolds; Dean Chou; Chetan Bettegowda; Ehud Mendel; Michael H Weber; Daniel M Sciubba
Journal:  Global Spine J       Date:  2017-06-01

9.  The Animal Lectin Galectin-8 Promotes Cytokine Expression and Metastatic Tumor Growth in Mice.

Authors:  Hadas Shatz-Azoulay; Yaron Vinik; Roi Isaac; Ulrike Kohler; Sima Lev; Yehiel Zick
Journal:  Sci Rep       Date:  2020-04-30       Impact factor: 4.379

10.  A 70-year-old male having advanced prostate cancer presenting with hypercalcemia and diffuse osteoblastic bone metastases: a case report.

Authors:  Wan-Hsiu Liao; Sheng-Hsiang Lin; Tsu-Tuan Wu
Journal:  Cases J       Date:  2009-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.